EXPLICIT-RCL: Study to Determine if Patients Exposed to General Anesthesia Significant Numbers of Times Would Increase the Risk for Intraoperative Awareness.

Sponsor
University of Chicago (Other)
Overall Status
Recruiting
CT.gov ID
NCT05857618
Collaborator
(none)
1,000
1
82.4
12.1

Study Details

Study Description

Brief Summary

This study will detect whether prior exposure to general anesthesia multiple times is associated with an increased incidence of awareness with explicit recall (AWR). This is especially important because patients who need to undergo multiple events of general anesthesia are medically some of the most vulnerable populations. The study hypothesizes that patients with significant exposure to general anesthesia have a higher incidence of AWR. This study may help clinicians and patients to better understand how to manage anesthesia care so that the safety and comfort of patients can be improved.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Each year, tens of millions of Americans undergo general anesthesia. One of the biggest fears patients have regarding general anesthesia is experiencing intraoperative awareness. That means that the patients "wake" during surgery and become aware of their environment. Prior studies have shown that intraoperative awareness with explicit recall (AWR) occurs in 0.1%-0.2% of patients undergoing general anesthesia. Patients have reported different forms of AWR, including feeling the sensation of pain, difficulty breathing, or recalling conversations. AWR can leave a lasting negative effect on patients. In one study, 56.3% of patients who experienced AWR met the diagnostic criteria for PTSD with functional impairment. Another study found that PTSD was experienced by as many as 70% of patients who had AWR.5 These patients fear undergoing further medical treatment requiring anesthesia and suffer quality of life issues related to their episode(s) of AWR. The goal of this study is to determine whether there is a particular group of patients, those that have been anesthetized many times, at high risk for AWR and then to design protocols to prevent this from happening.

    Rationale for Conducting this Research

    While the incidence of intraoperative awareness with explicit recall (AWR) is 0.1%-0.2% in general population undergoing general anesthesia, higher incidence has been reported in the populations with special risk factors, such as obstetric, cardiac and trauma surgeries. Patients with a history of awareness are at increased risk of intraoperative awareness. However, it is not certain whether this association is related to the number of anesthesia exposure or the development of resistance to anesthetics in these patients. Prior studies have demonstrated that the incidence of AWR in females is threefold higher than in males and that AWR is higher in patients with difficult airways and in patients with drug addiction. In addition, patients with an ASA Status of III-V had a greater than 2.4 odd of AWR than patients with an ASA Status of I-II. Most recently, we took care of two young adult patients who had more than 20 surgeries requiring general anesthesia since their childhood and reported multiple incidents of AWR. One of patients had a new episode of AWR during a regular surgery a few months ago despite extra measures were taken by her anesthesiologists. In addition, we found animals that were anesthetized multiple times showed change in their sensitivity to general anesthetics. To date, there has not been a study that has looked at whether patients who have undergone general anesthesia a significant number of times (n>20) have a higher incidence of AWR.

    Primary Objective

    To determine whether patients who have undergone general anesthesia significant number of times have a significantly higher incidence of intraoperative awareness with explicit recall (AWR) as compared to the general population.

    Secondary Objective Allows us to better understand the cause of AWR in this population. It may help us to improve clinical care and comfort for patients who are at a higher risk for intraoperative awareness.

    Patients that meet the eligibility criteria will be contacted by phone to provide consent to participate in the study. Patients who refuse to consent will not be included in the study and that data will not be saved. Of the patients who consent, a standardized phone interview by trained interviewers will be carried out and this data will be collected and stored in an encrypted computer hard drive. This data will be reviewed by anesthesiologists using a standard criteria to elucidate whether the patient experienced intraoperative awareness with explicit recall. The questionnaire includes the common complaints from the report of a North American anesthesia awareness registry. In addition to the questionnaire, the study team will perform a chart review on eligible patients collecting data on thier medical and surgical history, current medications and clinical situations when AWR occurred.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    1000 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    A Survey and Chart Review to Determine if Patients Exposed to General Anesthesia Significant Numbers of Times Would Increase the Risk for Intraoperative Awareness With Explicit Recall.
    Actual Study Start Date :
    Jul 19, 2017
    Anticipated Primary Completion Date :
    Jun 1, 2023
    Anticipated Study Completion Date :
    Jun 1, 2024

    Arms and Interventions

    Arm Intervention/Treatment
    Patients who have undergone exposer to General Anesthesia

    Patients who have undergone general anesthesia at the University of Chicago Medical Center more than 20 times or patients who have general anesthesia 5 or fewer times in the past.

    Outcome Measures

    Primary Outcome Measures

    1. Intraoperative Awareness with Explicit Recall for patients who underwent more than 20 general anesthesia events [Until study completion; up to 1 year.]

      The Number of incidences of intraoperative awareness with explicit recall with patients undergoing general anesthesia greater than 20 times using the 5-question modified Brice questionnaire

    Secondary Outcome Measures

    1. Intraoperative Awareness with Explicit Recall for patients who underwent less than 5 general surgeries involving general anesthesia [Until study completion; up to 1 year.]

      The Number of incidences of intraoperative awareness with explicit recall with patients undergoing general anesthesia less than 5 times using the 5-question modified Brice questionnaire

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    7 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients who have been exposed to general anesthesia greater than 20 times or who have been exposed to general anesthesia 5 or fewer times between January 1, 1985 and June 15, 2017

    • Patients/their Guardians who consent to participate in the study.

    • Patients for whom a determination of AWR status can be made by anesthesiologists based on a standardized criteria.

    • Must be at least 7 years of age or older.

    Exclusion Criteria:
    • Healthy volunteers,

    • Patients who cannot recall whether or not they have experienced intraoperative awareness with explicit recall

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Chicago Medical Center Chicago Illinois United States 60637

    Sponsors and Collaborators

    • University of Chicago

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University of Chicago
    ClinicalTrials.gov Identifier:
    NCT05857618
    Other Study ID Numbers:
    • IRB 17-0929
    First Posted:
    May 12, 2023
    Last Update Posted:
    May 12, 2023
    Last Verified:
    May 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University of Chicago
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 12, 2023